Cart
sales@molnova.com
Rezatomidine
CAS No. 847829-38-3
Rezatomidine ( AGN-203818; AGN203818; AGN 203818 )
Catalog No. M28010 CAS No. 847829-38-3
Rezatomidine (AGN-203818) is an effective and selective alpha2-adrenergic receptor antagonist for the treatment of chronic pain, including neuropathic pain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 264 | Get Quote |
|
| 5MG | 403 | Get Quote |
|
| 10MG | 592 | Get Quote |
|
| 25MG | 888 | Get Quote |
|
| 50MG | 1242 | Get Quote |
|
| 100MG | 1701 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRezatomidine
-
NoteResearch use only, not for human use.
-
Brief DescriptionRezatomidine (AGN-203818) is an effective and selective alpha2-adrenergic receptor antagonist for the treatment of chronic pain, including neuropathic pain.
-
DescriptionRezatomidine (AGN-203818) is an effective and selective alpha2-adrenergic receptor antagonist for the treatment of chronic pain, including neuropathic pain.
-
SynonymsAGN-203818; AGN203818; AGN 203818
-
PathwayOthers
-
TargetOther Targets
-
RecptorBRM/BRG1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number847829-38-3
-
Formula Weight232.4
-
Molecular FormulaC13H16N2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@H](c1c[nH]c(=S)[nH]1)c1cccc(C)c1C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Neville John ANTHONY, et al. Compounds and uses thereof. WO2019152437A1.
molnova catalog
related products
-
N-Acetyl-D-galactosa...
N-Acetyl-d-galactosamine (GalNAc) is a terminal essential amino sugar derived from galactose and forms the antigens of blood group A in humans.
-
Delphinidin-3-O-ruti...
Delphinidin-3-O-rutinoside chloride has antioxidant activity.
-
CNS-5161 hydrochlori...
CNS-5161 hydrochloride is a new antagonist of NMDA ion-channel. It interacts with the NMDA receptor/ion channel site to produce a noncompetitive blockade of the actions of glutamate.
